Radnor Capital Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Radnor Capital Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$772
+22.0%
20,458
+31.1%
0.15%
-7.8%
Q1 2023$633
-16.8%
15,605
+9.1%
0.17%
-10.2%
Q4 2022$761
-99.9%
14,3050.0%0.19%
-16.6%
Q3 2022$770,000
-18.5%
14,305
-2.7%
0.22%
-13.6%
Q2 2022$945,000
-2.7%
14,705
+17.4%
0.26%
+5.7%
Q1 2022$971,000
+17.6%
12,521
+30.1%
0.24%
+19.6%
Q4 2021$826,000
+43.4%
9,621
+34.5%
0.20%
+5.2%
Q2 2021$576,000
-4.5%
7,1530.0%0.19%0.0%
Q1 2021$603,000
+5.1%
7,1530.0%0.19%
+19.8%
Q4 2020$574,000
-0.2%
7,1530.0%0.16%
-16.1%
Q3 2020$575,000
-13.9%
7,153
-6.5%
0.19%
-19.9%
Q2 2020$668,000
+7.4%
7,6530.0%0.24%
-5.5%
Q1 2020$622,000
-0.2%
7,653
+2.7%
0.26%
+32.1%
Q4 2019$623,000
-4.4%
7,4530.0%0.19%
-9.8%
Q3 2019$652,000
+5.3%
7,453
-1.3%
0.21%
+4.9%
Q2 2019$619,000
-3.1%
7,553
-3.8%
0.20%
-2.4%
Q1 2019$639,000
+23.6%
7,8530.0%0.21%
+11.8%
Q4 2018$517,000
-14.5%
7,8530.0%0.19%
-2.6%
Q3 2018$605,000
+4.3%
7,8530.0%0.19%
-10.7%
Q2 2018$580,000
+13.5%
7,8530.0%0.22%
+23.6%
Q1 2018$511,000
+0.6%
7,8530.0%0.17%
+6.7%
Q4 2017$508,000
+6.9%
7,8530.0%0.16%
+1.2%
Q3 2017$475,0000.0%7,8530.0%0.16%0.0%
Q2 2017$475,000
+16.7%
7,8530.0%0.16%
+17.5%
Q1 2017$407,000
+6.8%
7,853
-8.7%
0.14%
+5.4%
Q4 2016$381,0008,5980.13%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders